BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18428211)

  • 1. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.
    Rao RD; Flynn PJ; Sloan JA; Wong GY; Novotny P; Johnson DB; Gross HM; Renno SI; Nashawaty M; Loprinzi CL
    Cancer; 2008 Jun; 112(12):2802-8. PubMed ID: 18428211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
    Rao RD; Michalak JC; Sloan JA; Loprinzi CL; Soori GS; Nikcevich DA; Warner DO; Novotny P; Kutteh LA; Wong GY;
    Cancer; 2007 Nov; 110(9):2110-8. PubMed ID: 17853395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
    Kautio AL; Haanpää M; Leminen A; Kalso E; Kautiainen H; Saarto T
    Anticancer Res; 2009 Jul; 29(7):2601-6. PubMed ID: 19596934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
    Silver M; Blum D; Grainger J; Hammer AE; Quessy S
    J Pain Symptom Manage; 2007 Oct; 34(4):446-54. PubMed ID: 17662571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.
    Vinik AI; Tuchman M; Safirstein B; Corder C; Kirby L; Wilks K; Quessy S; Blum D; Grainger J; White J; Silver M
    Pain; 2007 Mar; 128(1-2):169-79. PubMed ID: 17161535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.
    Bozorgi H; Ghahremanfard F; Motaghi E; Zamaemifard M; Zamani M; Izadi A
    J Ethnopharmacol; 2021 Dec; 281():114511. PubMed ID: 34390797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B; Pappagallo M; Knotkova H; Guleyupoglu N; Wallenstein S; Portenoy RK
    Clin Ther; 2007 Sep; 29(9):2022-30. PubMed ID: 18035201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy.
    Jose VM; Bhansali A; Hota D; Pandhi P
    Diabet Med; 2007 Apr; 24(4):377-83. PubMed ID: 17335465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
    Ettinger AB; Kustra RP; Hammer AE
    Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.
    Kremer I; Vass A; Gorelik I; Bar G; Blanaru M; Javitt DC; Heresco-Levy U
    Biol Psychiatry; 2004 Sep; 56(6):441-6. PubMed ID: 15364042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
    Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
    J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.